Stock listing
NASDAQ:AKTS Aktis Oncology, Inc. Stock
Home listing (NASDAQ) of Aktis Oncology, Inc.
Follow Aktis Oncology, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:AKTS
$16.42 USD +0.34 (+2.1%)
Close on Oct 21, 2026
- Day range
- $15.98 – $16.64 USDOct 21, 2026
- Volume
- 390,679 sharesOct 21, 2026
- Market cap
- $913.3M USDAt the close on Oct 21, 2026 · price × 55.62M shares outstanding
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:AKTS · Home | $16.42 USD | +0.34 (+2.1%) | 390,679 | $16.09 | $16.64 | $15.98 | $16.08 | Close on Oct 21, 2026 |
Daily closes
Last 3 months, Jul 21, 2026 – Oct 21, 2026 · NASDAQ:AKTS · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $16.42 | +0.34 | +2.1% | $16.09 | $16.64 | $15.98 | 390,679 | |
| $16.08 | +0.97 | +6.4% | $15.14 | $16.20 | $15.00 | 339,543 | |
| $15.11 | +0.05 | +0.3% | $15.19 | $15.32 | $14.84 | 353,421 | |
| $15.06 | -0.95 | -5.9% | $16.04 | $16.37 | $14.84 | 394,795 | |
| $16.01 | -0.48 | -2.9% | $16.65 | $17.08 | $15.77 | 667,740 | |
| $16.49 | -0.15 | -0.9% | $16.50 | $17.13 | $16.22 | 621,848 | |
| $16.64 | -0.70 | -4.0% | $17.26 | $17.61 | $16.60 | 327,900 | |
| $17.34 | -0.81 | -4.5% | $18.12 | $18.19 | $17.31 | 274,100 | |
| $18.15 | +0.41 | +2.3% | $17.74 | $18.21 | $17.59 | 361,000 | |
| $17.74 | -0.26 | -1.4% | $17.86 | $17.96 | $16.99 | 500,800 | |
| $18.00 | +0.14 | +0.8% | $17.72 | $18.35 | $17.70 | 294,100 | |
| $17.86 | -0.66 | -3.6% | $18.64 | $18.75 | $17.81 | 294,800 | |
| $18.52 | 0.00 | 0.0% | $18.47 | $18.68 | $17.84 | 283,000 | |
| $18.52 | 0.00 | 0.0% | $18.75 | $18.82 | $17.93 | 338,000 | |
| $18.52 | -0.95 | -4.9% | $19.41 | $20.08 | $18.31 | 305,200 | |
| $19.47 | -0.22 | -1.1% | $19.83 | $19.87 | $19.23 | 277,300 | |
| $19.69 | +0.34 | +1.8% | $19.30 | $19.73 | $19.06 | 194,700 | |
| $19.35 | -0.08 | -0.4% | $19.24 | $19.46 | $19.05 | 223,200 | |
| $19.43 | -0.20 | -1.0% | $19.71 | $19.81 | $18.97 | 518,900 | |
| $19.63 | -0.09 | -0.5% | $19.74 | $20.45 | $19.43 | 384,700 | |
| $19.72 | -2.39 | -10.8% | $21.87 | $21.87 | $19.67 | 589,200 | |
| $22.11 | +0.68 | +3.2% | $21.69 | $22.22 | $21.45 | 302,000 | |
| $21.43 | -0.45 | -2.1% | $22.06 | $22.06 | $20.75 | 614,300 | |
| $21.88 | -0.98 | -4.3% | $22.86 | $23.09 | $21.88 | 2,729,400 | |
| $22.86 | +0.15 | +0.7% | $23.04 | $23.97 | $22.45 | 500,900 | |
| $22.71 | +0.30 | +1.3% | $22.48 | $22.94 | $21.31 | 853,900 | |
| $22.41 | -0.76 | -3.3% | $23.21 | $23.21 | $22.18 | 290,400 | |
| $23.17 | -0.13 | -0.6% | $23.36 | $23.71 | $22.79 | 330,100 | |
| $23.30 | -0.64 | -2.7% | $24.36 | $24.54 | $23.25 | 228,600 | |
| $23.94 | -0.12 | -0.5% | $23.80 | $24.36 | $23.57 | 263,300 | |
| $24.06 | -0.96 | -3.8% | $25.57 | $26.00 | $24.03 | 377,400 | |
| $25.02 | -2.03 | -7.5% | $26.99 | $26.99 | $24.23 | 567,400 | |
| $27.05 | +0.40 | +1.5% | $26.18 | $27.20 | $26.18 | 159,200 | |
| $26.65 | -0.27 | -1.0% | $27.29 | $27.66 | $26.08 | 152,400 | |
| $26.92 | +0.93 | +3.6% | $26.12 | $27.03 | $25.71 | 253,500 | |
| $25.99 | +0.08 | +0.3% | $25.80 | $26.20 | $25.12 | 231,500 | |
| $25.91 | +0.13 | +0.5% | $25.57 | $26.05 | $25.14 | 213,600 | |
| $25.78 | -0.40 | -1.5% | $25.96 | $26.80 | $25.52 | 314,600 | |
| $26.18 | -0.33 | -1.2% | $26.32 | $27.18 | $26.15 | 210,600 | |
| $26.51 | -0.18 | -0.7% | $26.60 | $26.96 | $25.96 | 257,600 | |
| $26.69 | +0.71 | +2.7% | $26.30 | $26.89 | $25.47 | 601,241 | |
| $25.98 | +1.91 | +7.9% | $24.15 | $26.31 | $22.96 | 774,580 | |
| $24.07 | +0.07 | +0.3% | $24.33 | $25.00 | $24.00 | 226,400 | |
| $24.00 | -1.02 | -4.1% | $24.75 | $24.75 | $23.44 | 253,600 | |
| $25.02 | +0.02 | +0.1% | $26.28 | $26.28 | $24.42 | 216,500 | |
| $25.00 | +0.28 | +1.1% | $24.55 | $25.06 | $24.28 | 184,000 | |
| $24.72 | -0.21 | -0.8% | $24.89 | $24.89 | $24.11 | 163,100 | |
| $24.93 | +1.14 | +4.8% | $23.97 | $25.10 | $23.45 | 229,800 | |
| $23.79 | -0.21 | -0.9% | $24.37 | $24.57 | $23.65 | 156,300 | |
| $24.00 | -0.77 | -3.1% | $25.00 | $25.31 | $23.87 | 213,800 | |
| $24.77 | +0.67 | +2.8% | $24.79 | $25.01 | $23.86 | 209,200 | |
| $24.10 | -0.03 | -0.1% | $24.07 | $25.27 | $23.78 | 240,100 | |
| $24.13 | +0.69 | +2.9% | $24.07 | $24.55 | $23.82 | 154,800 | |
| $23.44 | +0.79 | +3.5% | $22.34 | $24.00 | $22.23 | 266,700 | |
| $22.65 | -0.19 | -0.8% | $23.02 | $23.48 | $22.50 | 248,400 | |
| $22.84 | +0.61 | +2.7% | $22.48 | $23.32 | $22.24 | 299,200 | |
| $22.23 | +0.16 | +0.7% | $22.07 | $22.33 | $21.46 | 314,700 | |
| $22.07 | -0.93 | -4.0% | $23.04 | $23.14 | $21.34 | 278,400 | |
| $23.00 | +0.61 | +2.7% | $22.24 | $23.21 | $21.80 | 331,100 | |
| $22.39 | -0.58 | -2.5% | $23.05 | $23.48 | $22.27 | 314,900 | |
| $22.97 | -1.24 | -5.1% | $24.22 | $24.26 | $22.54 | 312,200 | |
| $24.21 | +0.32 | +1.3% | $24.16 | $25.20 | $24.16 | 258,800 | |
| $23.89 | -0.12 | -0.5% | $24.06 | $24.58 | $23.40 | 193,800 | |
| $24.01 | -0.80 | -3.2% | $24.35 | $24.69 | $23.60 | 298,700 | |
| $24.81 | +0.18 | +0.7% | $24.59 | $25.03 | $24.15 | 208,000 | |
| $24.63 | +0.67 | +2.8% | $23.76 | $25.22 | $23.76 | 244,600 |
- Ticker
- NASDAQ:AKTS
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Sep 9, 2026
Aktis Oncology to Present at Upcoming September Investor Conferences
Latest deck · September 2026
Investor Presentation (September 2026)
Investor deck · 26 slides
Calls
Replays
Aktis Oncology (NASDAQ:AKTS) Q3 2024 Earnings Call
Mon, May 13, 2024 · 8:00 AM ET
Watch TranscriptAktis Oncology (NASDAQ:AKTS) Q2 2024 Earnings Call
Tue, Feb 13, 2024 · 8:00 AM ET
Watch TranscriptAktis Oncology (NASDAQ:AKTS) Q1 2024 Earnings Call
Mon, Nov 13, 2023 · 8:00 AM ET
Watch Transcript
Latest news
Aktis Oncology to Present at Upcoming September Investor Conferences
Sep 9, 2026
Closed $24.06 (-3.8%) on Sep 9, 2026
Aktis Oncology Reports Financial Results and Business Highlights for the Second Quarter 2026
Aug 13, 2026
Closed $24.93 (+4.8%) on Aug 14, 2026
Aktis Oncology to Present at the Jefferies Global Healthcare Conference
May 27, 2026
Closed $20.43 (+2.6%) on May 28, 2026
Aktis Oncology Reports First-in-Human Clinical Imaging and Dosimetry Data for AKY-2519 Demonstrating Robust Tumor Uptake and Limited Normal Tissue Exposures in Patients with B7-H3 Expressing Tumors
May 21, 2026
Closed $20.34 (+6.4%) on May 22, 2026
Aktis Oncology Reports Financial Results and Business Highlights for First Quarter 2026
May 11, 2026
Closed $19.73 (+8.0%) on May 12, 2026
Aktis Oncology to Present at the BofA Securities Health Care Conference
May 6, 2026
Closed $20.03 (+3.0%) on May 6, 2026
Aktis Oncology Initiates Phase 1b Clinical Trial for AKY-2519, a B7-H3 Miniprotein Radioconjugate, in Metastatic Castration-Resistant Prostate Cancer (mCRPC)
May 4, 2026
Closed $19.44 (+2.3%) on May 5, 2026
Aktis Oncology Announces Presentation of First Clinical Imaging and Dosimetry Data for AKY-2519 at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting
Apr 21, 2026
Closed $22.00 (+7.3%) on Apr 22, 2026
Aktis Oncology Appoints Industry Research and Development Veteran Glenn Gormley, MD, PhD to its Board of Directors
Apr 16, 2026
Closed $18.60 (+2.8%) on Apr 16, 2026
Decks
Investor Presentation (September 2026)
Investor deck · 26 slides · September 2026
Jefferies Global Healthcare Conference 2026
Conference · 21 slides · June 2026
Corporate Update (May 2026)
Corporate update · 25 slides · May 27, 2026
Investor Presentation (May 2026)
Investor deck · 16 slides · May 5, 2026
Aktis Oncology, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 13 in the last 12 months · 194 in all · newest Sep 9, 2026 · oldest 2020
- Calls
- 13 calls with a replay · 13 with a transcript · latest May 13, 2024
- Decks
- 6 decks · latest September 2026
Where Aktis Oncology, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:AKTS · Home listing · This page | NASDAQ | United States | USD |
| BOATS:AKTS | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Aktis Oncology, Inc.